Institute of Pharmaceutical Sciences opens at Lucknow University

LUCKNOW: The University of Lucknow (LU) is about to open an Institute of Pharmaceutical Sciences (IPS) spread over 8,170 square meters on its second campus in the Jankipuram area.

Students aspiring to a career in pharmacy will soon have a dedicated government institute in the state capital.

The proposal to open the institute under the direction of the Faculty of Engineering was given the green light at the university’s finance committee meeting and it will now be submitted to the executive committee on June 11 for final approval.

Congratulations!

You have successfully voted

The three-story high-tech building will be equipped with four state-of-the-art laboratories and will gradually be developed into a dedicated research institute with the establishment of modern laboratories for microbiology, pharmaceutical chemistry, central instrumentation, biotechnology, l human anatomy, physiology and pharmacognosy.

Construction work on the institute is expected to be completed by next year. Until then, pharmacy courses will be held at the Faculty of Engineering.

According to official sources, two self-funded courses – Bachelor in Pharmacy (B.Pharma) with 100 places and Diploma in Pharmacy (D.Pharma) with 60 places – will be offered at the institute for which 33 contractual faculties will be appointed.

The B.Pharma course will be four years (eight semesters) while the D.Pharma will be two years (annual model). The M.Pharma course may start after two years in accordance with the policy of the Pharmacy Council of India, New Delhi.

Application for both courses in the 2020-2021 academic session will be invited shortly once the university receives approval from the Pharmacy Council of India.

IPS will include four departments: pharmacy, pharmaceutical chemistry, pharmacology and pharmacognosy.

IPS Director Naveen Khare said: “The institute’s main objective is to excel in pharmacy education, to engage in cutting-edge research to advance healthcare. and drug discovery, which is the need of the hour during a Covid pandemic. Biomedical and clinical sciences and practices will be at the center of concerns. ”


Source link

About Perry Perrie

Perry Perrie

Check Also

Titanium Industry Leaders Join Hyperion Advisory Board

CHARLOTTE, North Carolina – (COMMERCIAL THREAD) –Hyperion Metals Limited (ASX: HYM) is pleased to announce …

Leave a Reply

Your email address will not be published. Required fields are marked *